vialaudit
ipamorelin · virginia

Is Ipamorelin legal in Virginia?

status · caveats apply
No FDA approval; PCAC voted NO Oct 29, 2024; on Category 2 'significant safety risks' list; WADA S2.2 explicitly named GH secretagogue. No state-level peptide restrictions beyond federal law in Virginia.

category: no approval · last verified May 13, 2026

§ 01

Quick answer

No FDA approval; PCAC voted NO Oct 29, 2024; on Category 2 'significant safety risks' list; WADA S2.2 explicitly named GH secretagogue. No state-level peptide restrictions beyond federal law in Virginia.
§ 02

Full status breakdown

Federal status

FDA approval
no approval
DEA scheduling
not scheduled
503A compounding
Bulks list: voted no
Do-not-compound list: on list
PCAC voted against inclusion Oct 29, 2024. Committee cited inadequate clinical efficacy/safety evidence, fluid retention/CHF/hyperglycemia concerns. On Category 2 (significant safety risks) as of April 2026.
PCAC review history
FDA Warning Letters
  • Jan 26, 2022Innoveix Pharmaceuticals Inc. (cited: ipamorelin, sermorelin, aod-9604) · letter
Shortage status
not currently on shortage list
Sale framing
Research-use-only posture: PCAC-rejected, Category 2; commercial human-use sale violates FDCA.
Personal possession: Not federally criminalized.

Virginia — state-specific

Sport-body status

WADA 2026
on prohibited list · class S2.2 · both
Explicitly named under S2.2 (GH secretagogues) alongside anamorelin, capromorelin, ibutamoren, lenomorelin, macimorelin, tabimorelin.
USADA
NCAA

What we couldn’t verify

§ 03

Also known as

Ipamorelin is also marketed or referenced under the following names (vendor pseudonyms, brand names, chemical identifiers):

  • Ipamorelin acetate
  • NNC 26-0161
  • GHRP
  • Ghrelin mimetic
§ 04

Disclaimer

§ 05

Related

the roundup · monthly

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 subscribers· 0 sponsored items· 11 issues since launch